4
Changes in Ownership
Mosaic ImmunoEngineering Inc. Filed Acc 0001144204-06-015658
CEO acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| POHL DAVID CEO | 2006-04-13 | Option exercise | +50,000 | $0.69 | $34,500 | 200,000 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| POHL DAVID CEO | 2005-06-22 | Grant or award · 2003 Stock Option Plan (right to buy) | −500,000 | 500,000 | D: show line 2 in the form | |||||
| POHL DAVID CEO | 2006-04-13 | Option exercise · 1996 Stock Option Plan (right to buy) | −50,000 | 0 | D: show line 3 in the form |
Loading xslF345X02/v040589_ex.xml…